TY - JOUR
T1 - Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases – Recommendations from the taskforce of the guideline workshop
AU - Gavin, James R.
AU - Rodbard, Helena W.
AU - Battelino, Tadej
AU - Brosius, Frank
AU - Ceriello, Antonio
AU - Cosentino, Francesco
AU - Giorgino, Francesco
AU - Green, Jennifer
AU - Ji, Linong
AU - Kellerer, Monika
AU - Koob, Susan
AU - Kosiborod, Mikhail
AU - Lalic, Nebojsa
AU - Marx, Nikolaus
AU - Prashant Nedungadi, T.
AU - Parkin, Christopher G.
AU - Topsever, Pinar
AU - Rydén, Lars
AU - Huey-Herng Sheu, Wayne
AU - Standl, Eberhard
AU - Olav Vandvik, Per
AU - Schnell, Oliver
N1 - Publisher Copyright:
© 2024 Elsevier B.V.
PY - 2024/5
Y1 - 2024/5
N2 - There is a mounting clinical, psychosocial, and socioeconomic burden worldwide as the prevalence of diabetes, cardiovascular disease (CVD), and chronic kidney disease (CKD) continues to rise. Despite the introduction of therapeutic interventions with demonstrated efficacy to prevent the development or progression of these common chronic diseases, many individuals have limited access to these innovations due to their race/ethnicity, and/or socioeconomic status (SES). However, practical guidance to providers and healthcare systems for addressing these disparities is often lacking. In this article, we review the prevalence and impact of healthcare disparities derived from the above-mentioned chronic conditions and present broad-based recommendations for improving access to quality care and health outcomes within the most vulnerable populations.
AB - There is a mounting clinical, psychosocial, and socioeconomic burden worldwide as the prevalence of diabetes, cardiovascular disease (CVD), and chronic kidney disease (CKD) continues to rise. Despite the introduction of therapeutic interventions with demonstrated efficacy to prevent the development or progression of these common chronic diseases, many individuals have limited access to these innovations due to their race/ethnicity, and/or socioeconomic status (SES). However, practical guidance to providers and healthcare systems for addressing these disparities is often lacking. In this article, we review the prevalence and impact of healthcare disparities derived from the above-mentioned chronic conditions and present broad-based recommendations for improving access to quality care and health outcomes within the most vulnerable populations.
KW - AGP
KW - Ambulatory glucose profile
KW - CGM
KW - Continuous glucose monitoring
KW - HbA1c
KW - Intermittently scanned CGM
KW - Real-time CGM
KW - Type 1 diabetes
KW - Type 2 diabetes
KW - isCGM
KW - rtCGM
UR - http://www.scopus.com/inward/record.url?scp=85191826521&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85191826521&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2024.111666
DO - 10.1016/j.diabres.2024.111666
M3 - Comment/debate
C2 - 38616041
AN - SCOPUS:85191826521
SN - 0168-8227
VL - 211
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
M1 - 111666
ER -